Bristol-Myers Squibb
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BMY
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies.
CEOChristopher S. Boerner
CEOChristopher S. Boerner
Employees34,100
Employees34,100
HeadquartersPrinceton, New Jersey
HeadquartersPrinceton, New Jersey
Founded1933
Founded1933
Employees34,100
Employees34,100
BMY Key Statistics
Market cap122.31B
Market cap122.31B
Price-Earnings ratio-13.89
Price-Earnings ratio-13.89
Dividend yield3.83%
Dividend yield3.83%
Average volume13.89M
Average volume13.89M
High today$61.51
High today$61.51
Low today$59.52
Low today$59.52
Open price$60.50
Open price$60.50
Volume4.52M
Volume4.52M
52 Week high$63.33
52 Week high$63.33
52 Week low$39.35
52 Week low$39.35
BMY News
Seeking Alpha 4d
Bristol Myers says over 50% responded to Sotyktu in psoriatic arthritis trialBristol-Myers Squibb (NYSE:BMY) on Saturday announced results from a late-stage trial for its psoriasis therapy Sotyktu in psoriatic arthritis, noting that more...
Analyst ratings
69%
of 26 ratingsBuy
26.9%
Hold
69.2%
Sell
3.8%